Cargando…

Can Mediastinal Lymphadenopathy Signal Pericarditis, Pericardial Effusion, and Severe Disease in a COVID-19 Patient?

Severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) has created a global pandemic. As we try to understand the virus, we are learning that it can affect many organ systems. Most commonly coronavirus disease 2019 (COVID-19) virus affects the respiratory tract and the lungs impairing oxygen t...

Descripción completa

Detalles Bibliográficos
Autores principales: Khan, Nabeel, Pandit, Sarbagya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8921382/
https://www.ncbi.nlm.nih.gov/pubmed/35308697
http://dx.doi.org/10.7759/cureus.22160
_version_ 1784669319603421184
author Khan, Nabeel
Pandit, Sarbagya
author_facet Khan, Nabeel
Pandit, Sarbagya
author_sort Khan, Nabeel
collection PubMed
description Severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) has created a global pandemic. As we try to understand the virus, we are learning that it can affect many organ systems. Most commonly coronavirus disease 2019 (COVID-19) virus affects the respiratory tract and the lungs impairing oxygen transport to the systemic circulation. Its effect on the cardiovascular system can be equally as devastating. Patients can develop pericarditis, myocarditis, and pericardial effusion that can at times lead to tamponade. Here we present an unusual case of a patient with COVID-19 pneumonia who presented with pericardial effusion along with enlarged mediastinal lymph nodes.
format Online
Article
Text
id pubmed-8921382
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-89213822022-03-18 Can Mediastinal Lymphadenopathy Signal Pericarditis, Pericardial Effusion, and Severe Disease in a COVID-19 Patient? Khan, Nabeel Pandit, Sarbagya Cureus Internal Medicine Severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) has created a global pandemic. As we try to understand the virus, we are learning that it can affect many organ systems. Most commonly coronavirus disease 2019 (COVID-19) virus affects the respiratory tract and the lungs impairing oxygen transport to the systemic circulation. Its effect on the cardiovascular system can be equally as devastating. Patients can develop pericarditis, myocarditis, and pericardial effusion that can at times lead to tamponade. Here we present an unusual case of a patient with COVID-19 pneumonia who presented with pericardial effusion along with enlarged mediastinal lymph nodes. Cureus 2022-02-12 /pmc/articles/PMC8921382/ /pubmed/35308697 http://dx.doi.org/10.7759/cureus.22160 Text en Copyright © 2022, Khan et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Internal Medicine
Khan, Nabeel
Pandit, Sarbagya
Can Mediastinal Lymphadenopathy Signal Pericarditis, Pericardial Effusion, and Severe Disease in a COVID-19 Patient?
title Can Mediastinal Lymphadenopathy Signal Pericarditis, Pericardial Effusion, and Severe Disease in a COVID-19 Patient?
title_full Can Mediastinal Lymphadenopathy Signal Pericarditis, Pericardial Effusion, and Severe Disease in a COVID-19 Patient?
title_fullStr Can Mediastinal Lymphadenopathy Signal Pericarditis, Pericardial Effusion, and Severe Disease in a COVID-19 Patient?
title_full_unstemmed Can Mediastinal Lymphadenopathy Signal Pericarditis, Pericardial Effusion, and Severe Disease in a COVID-19 Patient?
title_short Can Mediastinal Lymphadenopathy Signal Pericarditis, Pericardial Effusion, and Severe Disease in a COVID-19 Patient?
title_sort can mediastinal lymphadenopathy signal pericarditis, pericardial effusion, and severe disease in a covid-19 patient?
topic Internal Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8921382/
https://www.ncbi.nlm.nih.gov/pubmed/35308697
http://dx.doi.org/10.7759/cureus.22160
work_keys_str_mv AT khannabeel canmediastinallymphadenopathysignalpericarditispericardialeffusionandseverediseaseinacovid19patient
AT panditsarbagya canmediastinallymphadenopathysignalpericarditispericardialeffusionandseverediseaseinacovid19patient